CLASS I Drug recall · Reported 1 Jun 2016 · FDA Enforcement Report
Avastin (Bevacizumab) 1.25 mg/ syringe recalled by Pacifico National
Pacifico National is recalling Avastin (Bevacizumab) 1.25 mg/ syringe, Office Administration Only, AmEx Pharmacy, 1515, distributed nationwide in the US. The recall was initiated on 20 Jan 2015 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0870-2016
- FDA event ID
- 73560
- Recalling firm
- Pacifico National, Melbourne, FL
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- 20 Jan 2015
- FDA classified
- 25 May 2016
- Reported
- 1 Jun 2016
- Type
- Voluntary: Firm initiated
- Customers notified by
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Reason category
- Sterility
Timeline
| 20 Jan 2015 | Recall initiated by company | |
| 25 May 2016 | Classified by FDA | +491 days |
| 1 Jun 2016 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Non-Sterility: Product tested positive for bacterial contamination.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Avastin (Bevacizumab) 1.25 mg/0.05 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabeth St Suite J, Melbourne, FL 32901.
Where it was distributed
Nationwide
Questions about this recall
Why was it recalled?
Non-Sterility: Product tested positive for bacterial contamination.
Which lots are affected?
Lot #: 150116B, Exp. 04/16/2015; 150119R, Exp. 04/19/2015; 150316H, Exp. 06/14/2015
Where was it sold?
Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
1 other product · FDA event 73560This product is part of a recall event; the main page for the event is Avastin (Bevacizumab) 2 mg/ syringe recalled by Pacifico National.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS I | Avastin (Bevacizumab) 2 mg/ syringe recalled by Pacifico National | Pacifico National | Sterility | Nationwide |
More recalls from Pacifico National
All 5| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bevacizumab, 1.25 mg/ MJ Syringe Intravitreal Injection recalled | Pacifico National | Sterility | PR |
| Drug | CLASS II | Bevacizumab, 2.5 mg/, Norm-Ject Syringe Intravitreal recalled | Pacifico National | Sterility | PR |
| Drug | CLASS II | Bevacizumab 1.25 mg/ MJ syringe Intravitreal Injection recalled | Pacifico National | Packaging Defects | Nationwide |
| Drug | CLASS I | Avastin (Bevacizumab) 2 mg/ syringe recalled by Pacifico National | Pacifico National | Sterility | Nationwide |
Other Avastin (bevacizumab recalls
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Avastin (Bevacizumab) 2 mg/ syringe recalled by Pacifico National | Pacifico National | Sterility | Nationwide |